Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-11

Clinical Trial Update: Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update evaluates the potential therapeutic role of effervescent calcium-magnesium citrate in chronic kidney disease stage 5, spanning Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Effervescent Calcium-Magnesium Citrate

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: CKD Stage 5 | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING